5-(Thiophen-2-yl)nicotinonitrile

Catalog No.: 
ACCEXO061
CAS No.: 
1346687-10-2
Molecular Formula: 
C10H6N2S
Molecular Weight: 
186.24
5-(Thiophen-2-yl)nicotinonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%
1g95%
5g95%
10g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(Thiophen-2-yl)nicotinonitrile
IUPAC Name5-(thiophen-2-yl)nicotinonitrile
MDL No.MFCD19689007
Molecular FormulaC10H6N2S
Molecular Weight186.24
SMILESN#CC1=CN=CC(C2=CC=CS2)=C1
InChI KeyPHIJNJZPWVSQPM-UHFFFAOYSA-N
Synonym5-(Thiophen-2-yl)nicotinonitrile;3-Pyridinecarbonitrile, 5-(2-thienyl)-;5-(2-Thienyl)-3-pyridinecarbonitrile
CAS No.1346687-10-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCEXO061 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNPMO483 route compound structure diagram
    ACNPMO48335590-37-5In Stock
  2. Plus
  3. ACUXRB496 route compound structure diagram
    ACUXRB4966165-68-0In Stock
  4. Then
  5. ACCEXO061 route product structure diagram
    ACCEXO0611346687-10-2
Inquiry

2. ACCEXO061 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNPMO483 route compound structure diagram
    ACNPMO48335590-37-5In Stock
  4. Then
  5. ACCEXO061 route product structure diagram
    ACCEXO0611346687-10-2
Inquiry

3. ACCEXO061 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCEXO061 route product structure diagram
    ACCEXO0611346687-10-2
Inquiry

Comments (0)